Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Ovarian Cancer Health Center

Font Size

New Genetic Clues to Ovarian Cancer

Study Suggests Genetic Mutations May Be Linked to Ovarian Cancer
WebMD Health News
Reviewed by Laura J. Martin, MD

June 29, 2011 -- Multiple genetic mutations appear to be involved in the development of ovarian cancer, according to a new large-scale analysis of tumor samples.

Researchers from the Cancer Genome Atlas Research Network looked at 489 high-grade serous ovarian adenocarcinomas (HGS-OvCa). These are a kind of epithelial ovarian cancer, the most common kind.

Ovarian cancer is the fifth-leading cause of cancer death among U.S. women, the researchers write in the journal Nature.

Nearly 22,000 new cases were found in the U.S. in 2010, according to estimates. Nearly 14,000 U.S. women died from the cancer last year, the researchers report.

After analyzing the samples, the researchers found that mutations in a gene known as TP53 predominated. It was found in 96% of the tumor samples.

However, the researchers found mutations in nine other genes, including NF1, BRCA1 and BRCA2, RB1, and CDK12. BRCA1 and BRCA2 were mutated in 22% of the samples. The other seven mutated genes identified were only found in 2% to 6% of the samples.

''The mutation spectrum marks HGS-OvCa as completely distinct from other ovarian cancer histological subtypes," the researchers write.

Future Treatment Possibilities

Differences in survival varied by type of mutation. For instance, those with BRCA1/2 mutated cases had higher overall survival than those with BRCA1/2 wild type.

By uncovering the genetic mutations underlying different ovarian cancer subtypes, the hope is to pave the way for better, targeted treatments.

Ovarian cancer often has vague symptoms. For that reason, the disease is often diagnosed at advanced stages.

A woman should see her doctor if she has daily symptoms of bloating, feeling full quickly, difficulty eating, or pelvic or abdominal pain for more than a few weeks.

Women ages 55 and older are at higher risk. Women who give birth earlier and have multiple children are at lower risk than those who do neither. Women with a personal history of breast cancer or a family history of breast or ovarian cancer are at increased risk of ovarian cancer.

Today on WebMD

Ovarian cancer illustration
What are the symptoms?
doctory with x-ray
Get to know the Symptoms.
cancer cell
HPV is the top cause. Find out more.
Lung cancer xray
See it in pictures, plus read the facts.
Integrative Medicine Cancer Quiz
Lifestyle Tips for Depression Slideshow
Screening Tests for Women
Graphic of ovaries within reproductive system
Ovarian Cancer Marker
Pets Improve Your Health
Vitamin D
Healthy meal with salmon